הקסאקפרון טבליות
teva israel ltd - tranexamic acid - טבליה - tranexamic acid 500 mg - tranexamic acid - tranexamic acid - treatment of hemorrhage occuring in some forms of surgery, including prostatectomy. hematuria. menorrhagia. hereditary angioneurotic edema.
הקסאקפרון להזרקה
teva israel ltd - tranexamic acid - תמיסה להזרקה - tranexamic acid 500 mg / 5 ml - tranexamic acid - tranexamic acid - general fibrinolysis. this may occur in prostatic and pancreatic carcinoma following thoracic surgery and other major operative procedures, in obstetrical complications such as abruptio placentae and post-partum hemorrhage, in connection with thrombolytic therapy, and in initial and follow-up treatment following prostatectomy and bladder surgery. prior to, and following, dental surgery in hemophiliacs. epistaxis. conization of the cervix.
טראנקס להזרקה
tec-o-pharm-libra ltd - tranexamic acid - תמיסה להזרקה - tranexamic acid 500 mg / 5 ml - tranexamic acid
טרנקסמיק-מדו להזרקה
a.l. medi-market ltd. - tranexamic acid - תמיסה להזרקה - tranexamic acid 100 mg / 1 ml - tranexamic acid
הקסאקפרון 500 מ"ג
teva pharmaceutical indust.ltd - tranexamic acid 500 mg - tablets - tranexamic acid - treatment of hemorrhage occuring in some forms of surgery, including prostatectomy. hematuria. menorrhagia. hereditary angioneurotic edema.
נובוסבן אר.טי 1 מג בקבוקון
novo nordisk ltd., israel - eptacog alfa (activated) - אבקה להכנת תמיסה לזריקה - eptacog alfa (activated) 1 mg/vial - eptacog alfa (activated) - eptacog alfa (activated) - treatment of bleeding episodes and prevention of bleeding in those undergoing surgery of invasive procedures in the following patient goups : * in patients with congenital haemophilia with inhibitors to coagulation factors viii or ix > 5 bu, * in patients with congenital haemophilia who are expected to have a high anamnestic response to factor viii or factor ix administration, * in patients with acquired haemophilia, in patients with congenital fvii deficieny, * in patients with glanzmann's thropnbastenia with antibodies to gp iib-iiia and/or hla, and with past or present refractoriness to platelet transfusions.
נובוסבן אר.טי 2 מג בקבוקון
novo nordisk ltd., israel - eptacog alfa (activated) - אבקה להכנת תמיסה לזריקה - eptacog alfa (activated) 2 mg/vial - eptacog alfa (activated) - eptacog alfa (activated) - treatment of bleeding episodes and prevention of bleeding in those undergoing surgery of invasive procedures in the following patient goups : * in patients with congenital haemophilia with inhibitors to coagulation factors viii or ix > 5 bu, * in patients with congenital haemophilia who are expected to have a high anamnestic response to factor viii or factor ix administration, * in patients with acquired haemophilia, in patients with congenital fvii deficieny, * in patients with glanzmann's thropnbastenia with antibodies to gp iib-iiia and/or hla, and with past or present refractoriness to platelet transfusions.
נובוסבן אר.טי 5 מג בקבוקון
novo nordisk ltd., israel - eptacog alfa (activated) - אבקה להכנת תמיסה לזריקה - eptacog alfa (activated) 5 mg/vial - eptacog alfa (activated) - eptacog alfa (activated) - treatment of bleeding episodes and prevention of bleeding in those undergoing surgery of invasive procedures in the following patient goups : * in patients with congenital haemophilia with inhibitors to coagulation factors viii or ix > 5 bu, * in patients with congenital haemophilia who are expected to have a high anamnestic response to factor viii or factor ix administration, * in patients with acquired haemophilia, in patients with congenital fvii deficieny, * in patients with glanzmann's thropnbastenia with antibodies to gp iib-iiia and/or hla, and with past or present refractoriness to platelet transfusions.
טולפיין תמיסה להזרקה וטרינרי
eliezer linevitz ltd. - tolfenamic acid - תמיסה להזרקה - tolfenamic acid 4 %w/v
טולפיין תמיסה להזרקה וטרינרי
eliezer linevitz ltd. - tolfenamic acid - תמיסה להזרקה - tolfenamic acid 4 g / 100 ml